C-type natriuretic peptide has a negative inotropic effect on cardiac myocytes

Area of Science:

• Cardiovascular Physiology
• Molecular Cardiology
• Peptide Signaling

Background:

• C-type natriuretic peptide (CNP) exhibits vasodilatory and antimitogenic properties.
• The precise role of CNP in regulating cardiac function remains largely undefined.
• Understanding CNP's cardiac effects is crucial for cardiovascular research.

Purpose of the Study:

• To investigate the functional impact of CNP on neonatal rat cardiac myocytes.
• To elucidate the intracellular signaling mechanisms mediating CNP's effects on cardiac contraction.
• To determine the role of cyclic GMP and natriuretic peptide receptors in CNP-mediated cardiac responses.

Main Methods:

• Primary culture of neonatal rat cardiac myocytes.
• Measurement of myocyte contraction amplitude and intracellular cyclic GMP levels.
• Pharmacological blockade of natriuretic peptide receptors and cyclic GMP-dependent protein kinase.
• Assessment of intracellular Ca2+ transients.

Main Results:

• CNP significantly reduced the amplitude of cardiac myocyte contraction.
• CNP induced a significant accumulation of intracellular cyclic GMP.
• A membrane-permeable cyclic GMP analog mimicked CNP's negative inotropic effect.
• Blockade of natriuretic peptide receptors or protein kinase abolished CNP's effects.
• CNP did not alter Ca2+ transients.

Conclusions:

• CNP exerts a negative inotropic effect on neonatal rat cardiac myocytes.
• The CNP signaling pathway involves natriuretic peptide receptors and elevates intracellular cyclic GMP.
• Activation of protein kinase and subsequent attenuation of myofilament Ca2+ sensitivity mediate CNP's cardiac effects.